Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

NASDAQ Market News

NEXT STORY
The North America E. coli testing market is expected to reach US$ 1,165.0 million by 2027 from US$ 680.9 Mn in 2019
PREV STORY
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News

Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma

author_avatar
NASDAQ Market News

Curetis Announces Financial Results for the First Nine Months of 2018

Curetis Announces Financial Results for the First Nine Months of 2018 - Total year-on-year ...

author_avatar
NASDAQ Market News